Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

by Institute for Research in Biomedicine (IRB Barcelona)Oxaliplatin accumulation in the tumor microenvironment of a patient with colon cancer 44 days after treatment. Credit: IMIMPlatinum-based c

Updated on: February 23,2024

Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

by Institute for Research in Biomedicine (IRB Barcelona)Oxaliplatin accumulation in the tumor microenvironment of a patient with colon cancer 44 days after treatment. Credit: IMIMPlatinum-based c

Updated on:February 23,2024

Team identifies UGDH as indicator of tumor progression in clinical oncology and cancer biology

by Impact Journals LLCUGDH’s roles in cancer biology. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28514A new review paper titled "UDP-glucose dehydrogenase (UGDH) in clinical on

Updated on: May 27,2024

Team identifies UGDH as indicator of tumor progression in clinical oncology and cancer biology

by Impact Journals LLCUGDH’s roles in cancer biology. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28514A new review paper titled "UDP-glucose dehydrogenase (UGDH) in clinical on

Updated on:May 27,2024

A new way to predict complications after larynx cancer surgery

by Nicole Fawcett,University of MichiganRebecca Hoesli, M.D., and Matthew Spector, M.D., evaluate an image from the study Credit: University of Michigan Rogel Cancer CenterA technique that illum

Updated on: May 17,2024

A new way to predict complications after larynx cancer surgery

by Nicole Fawcett,University of MichiganRebecca Hoesli, M.D., and Matthew Spector, M.D., evaluate an image from the study Credit: University of Michigan Rogel Cancer CenterA technique that illum

Updated on:May 17,2024

Shape-shifting fat cells fuel breast cancer growth

Updated on: January 15,2024

Shape-shifting fat cells fuel breast cancer growth

Updated on:January 15,2024

'Bone in a dish' opens new window on cancer initiation, metastasis, bone healing

by Oregon Health & Science UniversityLuiz Bertassoni D.D.S., Ph.D., and Avathamsa Athirasala, M.Sc.Eng., inspect the 3D mineral structure populated with living cells, providing a unique model

Updated on: March 13,2024

'Bone in a dish' opens new window on cancer initiation, metastasis, bone healing

by Oregon Health & Science UniversityLuiz Bertassoni D.D.S., Ph.D., and Avathamsa Athirasala, M.Sc.Eng., inspect the 3D mineral structure populated with living cells, providing a unique model

Updated on:March 13,2024

Stopping the resistance of cancer cells to treatment

by Colin Poitras,University of ConnecticutCredit: CC0 Public DomainOne of the drawbacks of chemotherapy is that cancer patients can build up resistance to treatment over time, increasing their c

Updated on: April 01,2024

Stopping the resistance of cancer cells to treatment

by Colin Poitras,University of ConnecticutCredit: CC0 Public DomainOne of the drawbacks of chemotherapy is that cancer patients can build up resistance to treatment over time, increasing their c

Updated on:April 01,2024

Mini-colons advance colorectal cancer research

byEcole Polytechnique Federale de LausanneCredit: L. Francisco Lorenzo-Martín (EPFL)In a breakthrough for cancer research, scientists at EPFL have created lab-grown mini-colons that can accurate

Updated on: April 28,2024

Mini-colons advance colorectal cancer research

byEcole Polytechnique Federale de LausanneCredit: L. Francisco Lorenzo-Martín (EPFL)In a breakthrough for cancer research, scientists at EPFL have created lab-grown mini-colons that can accurate

Updated on:April 28,2024

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China PressThepeptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a P

Updated on: February 23,2024

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China PressThepeptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a P

Updated on:February 23,2024

Study sheds new light on mechanism of breast cancer treatment resistance

by Dana-Farber Cancer InstituteMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA study by researchers at Dana-Farber Cancer Institute has illumina

Updated on: March 01,2024

Study sheds new light on mechanism of breast cancer treatment resistance

by Dana-Farber Cancer InstituteMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA study by researchers at Dana-Farber Cancer Institute has illumina

Updated on:March 01,2024

Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAmong individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for h

Updated on: January 08,2024

Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAmong individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for h

Updated on:January 08,2024

Researchers identify lethal molecular alterations after current therapies fail patients with metastatic melanoma

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainIn a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the or

Updated on: January 30,2024

Researchers identify lethal molecular alterations after current therapies fail patients with metastatic melanoma

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainIn a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the or

Updated on:January 30,2024

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Updated on: January 02,2024

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Updated on:January 02,2024